{"count": 9, "results": [{"_id": "37047198", "pmid": 37047198, "pmcid": "PMC10093862", "title": "Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries", "journal": "Int J Mol Sci", "authors": ["Sivandzade F", "Alqahtani F", "Dhaibar H", "Cruz-Topete D", "Cucullo L"], "date": "2023-03-25T00:00:00Z", "doi": "10.3390/ijms24076219", "meta_date_publication": "2023 Mar 25", "meta_volume": "24", "meta_issue": "7", "meta_pages": "", "score": 50270.88, "text_hl": "The body weight of the animals receiving either @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@- or @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@RSG@@@-treated animals following @<m>DISEASE_Brain_Injuries_Traumatic</m> @DISEASE_MESH:D000070642 @@@TBI@@@ was not statistically different from the @<m>DISEASE_Brain_Injuries_Traumatic</m> @DISEASE_MESH:D000070642 @@@TBI@@@ controls.", "citations": {"NLM": "Sivandzade F, Alqahtani F, Dhaibar H, Cruz-Topete D, Cucullo L. Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries Int J Mol Sci. 2023 Mar 25;24(7):. PMID: 37047198", "BibTeX": "@article{37047198, title={Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries}, author={Sivandzade F and Alqahtani F and Dhaibar H and Cruz-Topete D and Cucullo L}, journal={Int J Mol Sci}, volume={24}, number={7}}"}}, {"_id": "34023358", "pmid": 34023358, "title": "Metformin reduces neuroinflammation and improves cognitive functions after traumatic brain injury.", "journal": "Neurosci Res", "authors": ["DiBona VL", "Shah MK", "Krause KJ", "Zhu W", "Voglewede MM", "Smith DM", "Crockett DP", "Zhang H"], "date": "2021-11-01T00:00:00Z", "doi": "10.1016/j.neures.2021.05.007", "meta_date_publication": "2021 Nov", "meta_volume": "172", "meta_issue": "", "meta_pages": "99-109", "score": 50261.727, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reduces @DISEASE_Neuroinflammatory_Diseases @DISEASE_MESH:D000090862 @@@neuroinflammation@@@ and improves cognitive functions after @<m>DISEASE_Brain_Injuries_Traumatic</m> @DISEASE_MESH:D000070642 @@@traumatic brain injury@@@.", "citations": {"NLM": "DiBona VL, Shah MK, Krause KJ, Zhu W, Voglewede MM, Smith DM, Crockett DP, Zhang H. Metformin reduces neuroinflammation and improves cognitive functions after traumatic brain injury. Neurosci Res. 2021 Nov;172():99-109. PMID: 34023358", "BibTeX": "@article{34023358, title={Metformin reduces neuroinflammation and improves cognitive functions after traumatic brain injury.}, author={DiBona VL and Shah MK and Krause KJ and Zhu W and Voglewede MM and Smith DM and Crockett DP and Zhang H}, journal={Neurosci Res}, volume={172}, pages={99-109}}"}}, {"_id": "32858129", "pmid": 32858129, "title": "Delayed metformin treatment improves functional recovery following traumatic brain injury via central AMPK-dependent brain tissue repair.", "journal": "Brain Res Bull", "authors": ["Fan YY", "Wang YJ", "Guo J", "Wu MN", "Zhang MS", "Niu BL", "Li Y", "Zhao J", "Yang CH", "Li Y", "Chen M", "Jiao XY"], "date": "2020-11-01T00:00:00Z", "doi": "10.1016/j.brainresbull.2020.08.021", "meta_date_publication": "2020 Nov", "meta_volume": "164", "meta_issue": "", "meta_pages": "146-156", "score": 50254.71, "text_hl": "Delayed @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment improves functional recovery following @<m>DISEASE_Brain_Injuries_Traumatic</m> @DISEASE_MESH:D000070642 @@@traumatic brain injury@@@ via central AMPK-dependent brain tissue repair.", "citations": {"NLM": "Fan YY, Wang YJ, Guo J, Wu MN, Zhang MS, Niu BL, Li Y, Zhao J, Yang CH, Li Y, Chen M, Jiao XY. Delayed metformin treatment improves functional recovery following traumatic brain injury via central AMPK-dependent brain tissue repair. Brain Res Bull. 2020 Nov;164():146-156. PMID: 32858129", "BibTeX": "@article{32858129, title={Delayed metformin treatment improves functional recovery following traumatic brain injury via central AMPK-dependent brain tissue repair.}, author={Fan YY and Wang YJ and Guo J and Wu MN and Zhang MS and Niu BL and Li Y and Zhao J and Yang CH and Li Y and Chen M and Jiao XY}, journal={Brain Res Bull}, volume={164}, pages={146-156}}"}}, {"_id": "32621159", "pmid": 32621159, "title": "Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway.", "journal": "Metab Brain Dis", "authors": ["Rahimi S", "Ferdowsi A", "Siahposht-Khachaki A"], "date": "2020-10-01T00:00:00Z", "doi": "10.1007/s11011-020-00594-3", "meta_date_publication": "2020 Oct", "meta_volume": "35", "meta_issue": "7", "meta_pages": "1135-1144", "score": 50254.14, "text_hl": "Neuroprotective effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Brain_Injuries_Traumatic</m> @DISEASE_MESH:D000070642 @@@traumatic brain injury@@@ in @SPECIES_10116 @@@rats@@@ is associated with the @GENE_PRKAA2 @GENE_78975 @@@AMP-activated protein kinase@@@ signaling pathway.", "citations": {"NLM": "Rahimi S, Ferdowsi A, Siahposht-Khachaki A. Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway. Metab Brain Dis. 2020 Oct;35(7):1135-1144. PMID: 32621159", "BibTeX": "@article{32621159, title={Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway.}, author={Rahimi S and Ferdowsi A and Siahposht-Khachaki A}, journal={Metab Brain Dis}, volume={35}, number={7}, pages={1135-1144}}"}}, {"_id": "36307002", "pmid": 36307002, "title": "Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study.", "journal": "Eur J Pharm Biopharm", "authors": ["Ebrahimi H", "Kazem Nezhad S", "Farmoudeh A", "Babaei A", "Ebrahimnejad P", "Akbari E", "Siahposht-Khachaki A"], "date": "2022-12-01T00:00:00Z", "doi": "10.1016/j.ejpb.2022.10.018", "meta_date_publication": "2022 Dec", "meta_volume": "181", "meta_issue": "", "meta_pages": "122-135", "score": 50248.07, "text_hl": "Design and optimization of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-loaded solid @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ nanoparticles for neuroprotective effects in a @SPECIES_10116 @@@rat@@@ model of diffuse @<m>DISEASE_Brain_Injuries_Traumatic</m> @DISEASE_MESH:D000070642 @@@traumatic brain injury@@@: A biochemical, behavioral, and histological study.", "citations": {"NLM": "Ebrahimi H, Kazem Nezhad S, Farmoudeh A, Babaei A, Ebrahimnejad P, Akbari E, Siahposht-Khachaki A. Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study. Eur J Pharm Biopharm. 2022 Dec;181():122-135. PMID: 36307002", "BibTeX": "@article{36307002, title={Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study.}, author={Ebrahimi H and Kazem Nezhad S and Farmoudeh A and Babaei A and Ebrahimnejad P and Akbari E and Siahposht-Khachaki A}, journal={Eur J Pharm Biopharm}, volume={181}, pages={122-135}}"}}, {"_id": "37214454", "pmid": 37214454, "pmcid": "PMC10196026", "title": "Effects of early adjunctive pharmacotherapy on serum levels of brain injury biomarkers in patients with traumatic brain injury: a systematic review of randomized controlled studies", "journal": "Front Pharmacol", "authors": ["Mansour NO", "Elnaem MH", "Abdelaziz DH", "Barakat M", "Dehele IS", "Elrggal ME", "Abdallah MS"], "date": "2023-05-05T00:00:00Z", "doi": "10.3389/fphar.2023.1185277", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1185277", "score": 50243.79, "text_hl": "Considering the possible disease-modifying effects on the pharmacokinetics of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_9606 @@@patients@@@ with severe @<m>DISEASE_Brain_Injuries_Traumatic</m> @DISEASE_MESH:D000070642 @@@TBI@@@. ", "citations": {"NLM": "Mansour NO, Elnaem MH, Abdelaziz DH, Barakat M, Dehele IS, Elrggal ME, Abdallah MS. Effects of early adjunctive pharmacotherapy on serum levels of brain injury biomarkers in patients with traumatic brain injury: a systematic review of randomized controlled studies Front Pharmacol. 2023;14():1185277. PMID: 37214454", "BibTeX": "@article{37214454, title={Effects of early adjunctive pharmacotherapy on serum levels of brain injury biomarkers in patients with traumatic brain injury: a systematic review of randomized controlled studies}, author={Mansour NO and Elnaem MH and Abdelaziz DH and Barakat M and Dehele IS and Elrggal ME and Abdallah MS}, journal={Front Pharmacol}, volume={14}, pages={1185277}}"}}, {"_id": "31093755", "pmid": 31093755, "title": "A randomized controlled trial on the efficacy, safety, and pharmacokinetics of metformin in severe traumatic brain injury.", "journal": "J Neurol", "authors": ["Taheri A", "Emami M", "Asadipour E", "Kasirzadeh S", "Rouini MR", "Najafi A", "Heshmat R", "Abdollahi M", "Mojtahedzadeh M"], "date": "2019-08-01T00:00:00Z", "doi": "10.1007/s00415-019-09366-1", "meta_date_publication": "2019 Aug", "meta_volume": "266", "meta_issue": "8", "meta_pages": "1988-1997", "score": 50061.92, "text_hl": "A randomized controlled trial on the efficacy, safety, and pharmacokinetics of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in severe @<m>DISEASE_Brain_Injuries_Traumatic</m> @DISEASE_MESH:D000070642 @@@traumatic brain injury@@@.", "citations": {"NLM": "Taheri A, Emami M, Asadipour E, Kasirzadeh S, Rouini MR, Najafi A, Heshmat R, Abdollahi M, Mojtahedzadeh M. A randomized controlled trial on the efficacy, safety, and pharmacokinetics of metformin in severe traumatic brain injury. J Neurol. 2019 Aug;266(8):1988-1997. PMID: 31093755", "BibTeX": "@article{31093755, title={A randomized controlled trial on the efficacy, safety, and pharmacokinetics of metformin in severe traumatic brain injury.}, author={Taheri A and Emami M and Asadipour E and Kasirzadeh S and Rouini MR and Najafi A and Heshmat R and Abdollahi M and Mojtahedzadeh M}, journal={J Neurol}, volume={266}, number={8}, pages={1988-1997}}"}}, {"_id": "29698747", "pmid": 29698747, "title": "Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-kappaB and MAPK signaling pathway.", "journal": "Brain Res Bull", "authors": ["Tao L", "Li D", "Liu H", "Jiang F", "Xu Y", "Cao Y", "Gao R", "Chen G"], "date": "2018-06-01T00:00:00Z", "doi": "10.1016/j.brainresbull.2018.04.008", "meta_date_publication": "2018 Jun", "meta_volume": "140", "meta_issue": "", "meta_pages": "154-161", "score": 50056.676, "text_hl": "Neuroprotective effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Brain_Injuries_Traumatic</m> @DISEASE_MESH:D000070642 @@@traumatic brain injury@@@ in @SPECIES_10116 @@@rats@@@ associated with NF-kappaB and MAPK signaling pathway.", "citations": {"NLM": "Tao L, Li D, Liu H, Jiang F, Xu Y, Cao Y, Gao R, Chen G. Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-kappaB and MAPK signaling pathway. Brain Res Bull. 2018 Jun;140():154-161. PMID: 29698747", "BibTeX": "@article{29698747, title={Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-kappaB and MAPK signaling pathway.}, author={Tao L and Li D and Liu H and Jiang F and Xu Y and Cao Y and Gao R and Chen G}, journal={Brain Res Bull}, volume={140}, pages={154-161}}"}}, {"_id": "29228667", "pmid": 29228667, "pmcid": "PMC5716707", "title": "Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway", "journal": "Oncotarget", "authors": ["Tang G", "Yang H", "Chen J", "Shi M", "Ge L", "Ge X", "Zhu G"], "date": "2017-08-10T00:00:00Z", "doi": "10.18632/oncotarget.20105", "meta_date_publication": "2017 Nov 17", "meta_volume": "8", "meta_issue": "58", "meta_pages": "97977-97989", "score": 50042.96, "text_hl": "Previous studies have suggested that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ provides neuroprotective effects against @DISEASE_Ischemia @DISEASE_MESH:D007511 @@@ischemia@@@, @<m>DISEASE_Brain_Injuries_Traumatic</m> @DISEASE_MESH:D000070642 @@@brain trauma@@@ and other @DISEASE_Brain_Damage_Chronic @DISEASE_MESH:D001925 @@@brain damage@@@, but whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ protects a @DISEASE_Arthritis_Infectious @DISEASE_MESH:D001170 @@@septic@@@ brain remains unknown. ", "citations": {"NLM": "Tang G, Yang H, Chen J, Shi M, Ge L, Ge X, Zhu G. Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway Oncotarget. 2017 Nov 17;8(58):97977-97989. PMID: 29228667", "BibTeX": "@article{29228667, title={Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway}, author={Tang G and Yang H and Chen J and Shi M and Ge L and Ge X and Zhu G}, journal={Oncotarget}, volume={8}, number={58}, pages={97977-97989}}"}}]}